vquqgms.info

According to the new market research report by IndustryARC titled “Astaxanthin Market: By Product Type (Synthetic Astaxanthin, Astaxanthin Rich Paracoccus Bacteria, Pluviallis Microalgae Astaxanthin, Aematococcus); By Form (Liquid, Dry); By Applications (Dietary Supplements, Animal Health & Aquaculture, Cosmetics, Food & Beverages, Feed); By Source (Natural, Synthetic) & Geography – (2018-2023)”, the market will be driven by the rise in health-conscious populace and exponential demand for natural food coloring agents.The Americas region holds the largest market share in the Astaxanthin Market However, Asia Pacific is estimated to have the highest growth. As the anti-ageing creams and other skin products are becoming much sought after than ever before, the usage of Astaxanthin becomes ubiquitous in this region. The key applications in this region include cosmetics and dietary supplements among others.Selected Impact Analysis Done in the Full ReportAstaxanthin is responsible for the red color in many sea creatures such as crayfish, krill, and salmon. Astaxanthin gives red color to many sea creatures such as crayfish, krill and salmon their red color.Astaxanthin has been reported in many studies for its high antioxidant and skin-friendly properties.Paracoccus Bacteria, Astaxanthin Rich Phaffia Yeast, and Synthetic Astaxanthin are predominantly used in the aquaculture sector, while the Astaxanthin derived from H. Pluvialis microalgae is the main source for human applications such as food & beverages.Excerpts on Market Growth FactorsAquaculture and Animal feed are the major applications, while Carotenoid has been used for coloring fishes and improving the texture of animals.Nutraceutical segment is anticipated to have a rapid growth during the forecast period.Astaxanthin Softgels are estimated to register an agile growth rate during the forecast period.Synthetic source will acquire a major share in the market.Natural Sources are estimated to witness a swashbuckling over the forecast period.Astaxanthin can be manufactured from natural sources. The high yield of carotenoid and low maintenance cost will drive the growth of natural sources, which in turn drives the growth of Astaxanthin.Key Players of Astaxanthin Market:Astaxanthin is an Oligopolistic in nature and dominated by limited number of key players.Koninklijke DSM N.V is one of the key players of the Astaxanthin Market. The Heerlen headquarters company which has more than 20,000 employees worldwide witnessed € 8,632 net sales and € 1,781 net profit in 2017.BASF SE is another conglomerate that earned $816 million of revenue through operations for the year 2017.In September 2014, Algatech entered into an R&D agreement with SCHOTT AG, a German company, to boost its productivity of its closed tube cultivation system.The Astaxanthin Market Report is Segmented as Indicated Below:A. By Source:1. Natural1.1 Yeast1.2 Krill/Shrimp1.3 Microalgae2. SyntheticB. By Product1. Dried Biomass/Powder2. Oil3. Soft gels4. Liquid5. OthersC. By Application1. Dietary Supplement/Nutraceuticals2. Cosmetics3. Animal health and Aquaculture4. Food & Beverages5. FeedD. by Form1. Liquid2. Dry FormE. By Geography (Covers 12 + Countries)F. By EntropyCompanies Cited/Referenced/Interviewed:1. Cyanotech Corporation2. Otsuka Pharmaceutical Co., Ltd3. Valensa International4. Fuji Chemical Industries Co., Ltd5. Divis Laboratories Ltd6. Beijing Ginko Group (BGG)7. Igene Biotechnology Inc8.Piveng Inc9.Fenchem Biotek Ltd10.Algatechnologies11. Cardax, Inc12. Supreme Biotechnologies13. Parry Nutraceuticals14.Alga Technologies15. BlueOcean NutraSciences Inc16. MicroA AS, EID Parry (India) Ltd17. Heliae Development, LLCWhat can you expect from the report?The Astaxanthin Market Report is prepared with the main agenda to cover the following 20 points:1.Market Size by Product Categories2.Market trends3.Manufacturer Landscape4.Distributor Landscape5.Pricing Analysis6.Top 10 End user Analysis7.Product Benchmarking8.Product Developments9.Mergers & Acquisition Analysis10.Patent Analysis11.Demand Analysis (By Revenue & Volume)12.Country level Analysis (15+)13.Competitor Analysis14.Market Shares Analysis15.Value Chain Analysis16.Supply Chain Analysis17.Strategic Analysis18.Current & Future Market Landscape Analysis19.Opportunity Analysis20.Revenue and Volume AnalysisFAQ:Does IndustryARC publish country, geography or application based reports in Astaxanthin Market?Yes, we do have separate reports as mentioned below:1.Americas Market for Astaxanthin (2018-2023)2.Europe Market for Astaxanthin (2018-2023)3.APAC Market for Astaxanthin (2018-2023)4.RoW Market for Astaxanthin (2018-2023)5.Natural Market for Astaxanthin (2018-2023)6.Synthetic Market for Astaxanthin (2018-2023)7.Dried Biomass/Powder Market for Astaxanthin (2018-2023)8.Oil Market for Astaxanthin (2018-2023)9.Soft gels Market for Astaxanthin (2018-2023)10.Liquid Market for Astaxanthin (2018-2023)11.Dietary Supplement/Nutraceuticals Market for Astaxanthin (2018-2023)12.Cosmetics Market for Astaxanthin (2018-2023)13.Animal health and Aquaculture Market for Astaxanthin (2018-2023)14.Food & Beverages Market for Astaxanthin (2018-2023)15.Feed Market for Astaxanthin (2018-2023)16.Liquid Market for Astaxanthin (2018-2023)17.Dry Form Market for Astaxanthin (2018-2023)Does IndustryARC customize these reports and charge additionally for limited customization?Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:1.Increase the level of data in application or end user industry.2.Increase the number of countries in geography chapter.3.Find out market shares for other smaller companies or companies which are of interest to you.4.Company profiles can be requested based on your interest.5.Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end use segment.Access Report:https://industryarc.com/Report/16597/astaxanthin-market.htmlAny other major customizations can be discussed with our team, we can provide a separate quote based on your requirement. You can drop in an e-mail to [email protected] to discuss more about our consulting services.

3D technology can be traced all the way back to the beginning of photography. In 1844 David Brewster invented the Stereoscope. It was a new invention that could take photographic images in 3D. Later, Louis Jules Duboscq took that invention and improved on it. Louis took a picture of Queen Victoria using the improved technology and displayed it at the Great Exhibition in 1851. This picture became very well known throughout the world. Steroscopic cameras started to catch on and became fairly common for personal use by World War II.In 1855 the Kinematascope, a stereo animation camera, was invented. It was able to create 3d motion pictures. In 1915 the first anaglyph movie was produced. Anaglyph technology used 3d glasses with 2 different color lenses that would direct an image to each eye. In 1890 William Friese-Greene, a British film pioneer, filed a patent for the 3D movie process. In 1922 the first public 3D movie, “The Power of Love”, was displayed. In 1935 the first 3D Color movie was produced. The use of the technology would remain dormant for over a decade.In the 1950s, 3D technology made a come back. During this era, TVs had become extremely popular and had started appearing in many households. In the 50s a number of 3D movies were being produced. In 1952 “Bwana Devil” by United Artists was shown across the United States. This was the first 3D movie of the 50s. The film was shot using a process called Natural Vision. This process was pitched to Hollywood studios but they all passed. A year later, in 1953, “House of Wax” was released in 3D. “Dial M for Murder” was originally planned to be released in 3D, but Alfred Hitchcock decided to release the movie in 2D to maximize profits. Not all movie theaters were equipped with the 3D technology. 3D films were also being developed outside of the United States. In 1947 The Soviet Union released their first full length 3D movie, “Robinson Crusoe”.In the 1960s a new technology called Space-Vision 3D was released. This technology took two images and printed them over each other on a single strip. Unlike previous 3D technologies, it required a single projector with a special lens. This new technology removed the need to use two cameras to display 3D movies. Two camera systems were difficult to use, because it required that the two cameras were perfectly synced. The first movie to use this technology was “The Bubble”. The movie was panned by critics, but the 3D experience still brought huge audiences. It became a profitable movie, making the new technology ready for promotion to other studios.In 1970, Allan Silliphant and Chris Condon developed Stereovision. This was a new 3D technology that put two images squeezed together side by side on a single strip of 35 mm film. This technology used a special anamorphic lens that would widen the picture using a series of polaroid filters. The first movie to be released in Stereovision was a softcore sex comedy called “The Stewardesses”. The movie cost only $100,000 USD to make and it earned an amazing $27 million in North America.In the early 1980s many movies were released in 3D using the same process as Space Vision. Some of the movies that were released were Amityville 3-D, Friday the 13th Part III, and Jaws 3-D. In the mid 1980s, IMAX began producing documentary films in 3D. IMAx’s 3D technology emphasized mathmatical correctness and this eliminated the eye fatigue that was seen in previous 3D technologies. In 1986, Canada had developed the first 3D movie that used polarized glasses. It was called “Echos of the Sun” and was created for Expo 86.During the 1990s, many films were released in IMAX 3D. The most successful IMAX 3D film released during this time was “Into the Deep”. The first IMAX 3D fiction film, “Wings of Courage” was released in 1996.During the 2000s, many big studio movies were released in 3D. In 2003, James Cameron released Ghosts of the Abyss. This was the first full length 3D IMAX feature film. This movie used the latest IMAX 3D technology called Reality Camera System. The technology used the latest HD video cameras and was developed by Vince Pace. This same technology was used in “Spy Kids 3D: Game over”, “Aliens of the Deep”, and “The Adventures of Sharkboy and Lavagirl in 3-D”. In 2004 the first full length animated 3D movie was released. It was called “The Polar Express”. This movie was so successful in 3D that it prompted a great interest in 3D animated films. The 3D version of the film earned 14x as much per screen as the 2D version. In 2005, The Mann’s Chinese 6 theater in Hollywood became the first commercial movie theater to have the Digital 3D technology. In 2007 Scar 3D was released internationally and it was the first film to be filmed using a completely digital workflow.In 2010 Sky UK made a big push towards 3D television. On January 1st, the first 3D channel began broadcasting in South Korea. The channel displays educational shows, animated shows, sporting events, documentaries and musical performances all in 3D, 24 hours a day, 7 days a week.We should expect that the use of 3D technology will continue and expand in to the normal household. Most major electronics manufacturers are planning the release of their 3D television lines. As the technology ages, expect prices to go lower and lower, and as they prices drop, more and more people will purchase 3D television sets.

Are we experiencing an identity crisis within the Body of Christ? Are we true worshippers of God or are we entertainers for the world? Is it okay to entertain people in order to get their attention about the Word of God? Before I address these questions, I would like to give a definition of worship and entertainment. This will enable us to be able to identify ourselves. Worship is an expression of love and devotion toward our heavenly Father. Entertainment is an activity designed to give people pleasure or relaxation. Entertainment is anything that causes enjoyment. According to both definitions, worship is clearly God-centered and entertainment is man-centered. When we worship, our main focus should be to praise, honor, exalt, and please God. Entertainment is basically an avenue used to amuse or give pleasure to our own flesh and others. Worship and entertainment are direct opponents within the Body of Christ. The worshipper wants to praise and honor God; but, the entertainer wants to be exalted and please others. Which one are you?A true worshipper is a child of God who strives to live a lifestyle of obedience according to the Word of God and the guidance of the Holy Spirit. God is the center of our worship and also orchestrates our worship (1 Corinthians 14:40). Through His Word, we have been given clear instructions on how we should worship Him. A worshipper knows that he or she must be a believer in Christ in order to worship God. A worshipper knows that God is a Spirit and must be worshipped in spirit and in truth (John 4:23-24). All worshippers’ hearts should be focused on pleasing God in their thoughts and their actions. Every worship experience is for the pleasure of God, not for man. Please do not misunderstand; worshipping God should be a joyous occasion for the believer. We can worship Him through musical instruments, song, and prayer. We must learn that emotions are not the main focus or incentive to worship; but God is the center of attention. A true worshipper praises and honors God because He is worthy of all that we have to offer and it is a commandment for His people (Exodus 20:3). True worship keeps us focus on the sovereignty of God and our eternal gratitude for His perfect expression of love for us through Jesus Christ.An entertainer in the Body of Christ is someone who does not understand or does not care that God is the main focus of worship. They have the impression that in order to get people to listen to the gospel; you have to provide entertainment to keep them coming back to church services. An entertainer thinks that they are to “get something out” of worship and feel good during and after the process. The first mistake with this mindset is thinking that worship is about you. The Spirit of the Lord is the author, leader and center of our faith and worship, not the flesh (Colossians 1:16-17). The Word of God does not need the aid of gimmicks or theatrics. Jesus stated that His people will hear His voice and follow His instructions (John 10:27). Entertainment will attract great numbers concerning people in worship services; but, will take the focus off God. When people come to worship services for entertainment, they will always seek the next big gimmick or show. Once they are no longer amused, they will go elsewhere to seek entertainment. Fun and games in worship service will never reach or sustain anyone. The Word of God and the Holy Spirit changes people’ lives (Proverbs 3:5). Entertainment is an event that stimulates our emotions; but, the Spirit of the Lord will sustain and cultivate us in our Christian walk.We have taken a look at the man in the mirror concerning worship and entertainment. Can you see yourself? Are you are worshipper or an entertainer? Hopefully, we have arrived at a truthful answer. Worship is not an entertainment event; but a long-term commitment. The entire life of the believer is a worship experience. We should live our lives as a “light” to a lost world that will continually bring praise and honor to our heavenly Father. Remember, worship is not a short-term event to entertain man; but, a lifetime commitment to the glory of God (Isaiah 26:4).

Summary
SPDN is not the largest or oldest way to short the S&P 500, but it’s a solid choice.
This ETF uses a variety of financial instruments to target a return opposite that of the S&P 500 Index.
SPDN’s 0.49% Expense Ratio is nearly half that of the larger, longer-tenured -1x Inverse S&P 500 ETF.
Details aside, the potential continuation of the equity bear market makes single-inverse ETFs an investment segment investor should be familiar with.
We rate SPDN a Strong Buy because we believe the risks of a continued bear market greatly outweigh the possibility of a quick return to a bull market.
Put a gear stick into R position, (Reverse).
Birdlkportfolio

By Rob Isbitts

Summary
The S&P 500 is in a bear market, and we don’t see a quick-fix. Many investors assume the only way to navigate a potentially long-term bear market is to hide in cash, day-trade or “just hang in there” while the bear takes their retirement nest egg.

The Direxion Daily S&P 500® Bear 1X ETF (NYSEARCA:SPDN) is one of a class of single-inverse ETFs that allow investors to profit from down moves in the stock market.

SPDN is an unleveraged, liquid, low-cost way to either try to hedge an equity portfolio, profit from a decline in the S&P 500, or both. We rate it a Strong Buy, given our concern about the intermediate-term outlook for the global equity market.

Strategy
SPDN keeps it simple. If the S&P 500 goes up by X%, it should go down by X%. The opposite is also expected.

Proprietary ETF Grades
Offense/Defense: Defense

Segment: Inverse Equity

Sub-Segment: Inverse S&P 500

Correlation (vs. S&P 500): Very High (inverse)

Expected Volatility (vs. S&P 500): Similar (but opposite)

Holding Analysis
SPDN does not rely on shorting individual stocks in the S&P 500. Instead, the managers typically use a combination of futures, swaps and other derivative instruments to create a portfolio that consistently aims to deliver the opposite of what the S&P 500 does.

Strengths
SPDN is a fairly “no-frills” way to do what many investors probably wished they could do during the first 9 months of 2022 and in past bear markets: find something that goes up when the “market” goes down. After all, bonds are not the answer they used to be, commodities like gold have, shall we say, lost their luster. And moving to cash creates the issue of making two correct timing decisions, when to get in and when to get out. SPDN and its single-inverse ETF brethren offer a liquid tool to use in a variety of ways, depending on what a particular investor wants to achieve.

Weaknesses
The weakness of any inverse ETF is that it does the opposite of what the market does, when the market goes up. So, even in bear markets when the broader market trend is down, sharp bear market rallies (or any rallies for that matter) in the S&P 500 will cause SPDN to drop as much as the market goes up.

Opportunities
While inverse ETFs have a reputation in some circles as nothing more than day-trading vehicles, our own experience with them is, pardon the pun, exactly the opposite! We encourage investors to try to better-understand single inverse ETFs like SPDN. While traders tend to gravitate to leveraged inverse ETFs (which actually are day-trading tools), we believe that in an extended bear market, SPDN and its ilk could be a game-saver for many portfolios.

Threats
SPDN and most other single inverse ETFs are vulnerable to a sustained rise in the price of the index it aims to deliver the inverse of. But that threat of loss in a rising market means that when an investor considers SPDN, they should also have a game plan for how and when they will deploy this unique portfolio weapon.

Proprietary Technical Ratings
Short-Term Rating (next 3 months): Strong Buy

Long-Term Rating (next 12 months): Buy

Conclusions
ETF Quality Opinion
SPDN does what it aims to do, and has done so for over 6 years now. For a while, it was largely-ignored, given the existence of a similar ETF that has been around much longer. But the more tenured SPDN has become, the more attractive it looks as an alternative.

ETF Investment Opinion

SPDN is rated Strong Buy because the S&P 500 continues to look as vulnerable to further decline. And, while the market bottomed in mid-June, rallied, then waffled since that time, our proprietary macro market indicators all point to much greater risk of a major decline from this level than a fast return to bull market glory. Thus, SPDN is at best a way to exploit and attack the bear, and at worst a hedge on an otherwise equity-laden portfolio.

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.

US Markets were trading in the green on Friday with Dow 30 trading at 30,678.80, up by 1.14%. While S&P 500 was trading at 3,701.66, up by 0.98% and Nasdaq Composite 10,690.60 was also up by 0.71 per cent

Twitter Facebook Linkedin
US Markets in green on Friday; Dow 30 up over 345 points, Nasdaq Composite, S&P 500 up nearly 1%
Earlier today, Indian stock markets ended the week on a winning note. It was the sixth straight gains for equity markets. Source: Reuters
US Markets were trading in the green on Friday with Dow 30 trading at 30,678.80, up by 345.25 points or1.14 per cent. While S&P 500 was trading at 3,701.66, up by 35.88 points or 0.98 per cent and Nasdaq Composite 10,690.60 was also up 75.75 points or 0.71 per cent. A Reuters report said that today’s strength was on the back of a report which said the Federal Reserve will likely debate on signaling plans for a smaller interest rate hike in December, reversing declines set off by social media firms after Snap Inc’s ad warning.

Source: Comex

Nasdaq Top Gainers and Losers

Source: Nasdaq

Earlier today, Indian stock markets ended the week on a winning note. It was the sixth straight gains for equity markets. The BSE Sensex ended at 59,307.15, up by 104.25 points or 0.18 per cent from the Thursday closing level. Meanwhile, the Nifty50 index closed at 17,590.00, higher by 26.05 points or 0.15 per cent. In the 30-share Sensex, 13 stocks gained while the remaining 17 ended on the losing side. In the 50-stock Nifty50, 21 stocks advanced while 29 declined.

There are several potential financing options available to cash-strapped businesses that need a healthy dose of working capital. A bank loan or line of credit is often the first option that owners think of – and for businesses that qualify, this may be the best option.

In today’s uncertain business, economic and regulatory environment, qualifying for a bank loan can be difficult – especially for start-up companies and those that have experienced any type of financial difficulty. Sometimes, owners of businesses that don’t qualify for a bank loan decide that seeking venture capital or bringing on equity investors are other viable options.

But are they really? While there are some potential benefits to bringing venture capital and so-called “angel” investors into your business, there are drawbacks as well. Unfortunately, owners sometimes don’t think about these drawbacks until the ink has dried on a contract with a venture capitalist or angel investor – and it’s too late to back out of the deal.

Different Types of Financing

One problem with bringing in equity investors to help provide a working capital boost is that working capital and equity are really two different types of financing.

Working capital – or the money that is used to pay business expenses incurred during the time lag until cash from sales (or accounts receivable) is collected – is short-term in nature, so it should be financed via a short-term financing tool. Equity, however, should generally be used to finance rapid growth, business expansion, acquisitions or the purchase of long-term assets, which are defined as assets that are repaid over more than one 12-month business cycle.

But the biggest drawback to bringing equity investors into your business is a potential loss of control. When you sell equity (or shares) in your business to venture capitalists or angels, you are giving up a percentage of ownership in your business, and you may be doing so at an inopportune time. With this dilution of ownership most often comes a loss of control over some or all of the most important business decisions that must be made.

Sometimes, owners are enticed to sell equity by the fact that there is little (if any) out-of-pocket expense. Unlike debt financing, you don’t usually pay interest with equity financing. The equity investor gains its return via the ownership stake gained in your business. But the long-term “cost” of selling equity is always much higher than the short-term cost of debt, in terms of both actual cash cost as well as soft costs like the loss of control and stewardship of your company and the potential future value of the ownership shares that are sold.

Alternative Financing Solutions

But what if your business needs working capital and you don’t qualify for a bank loan or line of credit? Alternative financing solutions are often appropriate for injecting working capital into businesses in this situation. Three of the most common types of alternative financing used by such businesses are:

1. Full-Service Factoring – Businesses sell outstanding accounts receivable on an ongoing basis to a commercial finance (or factoring) company at a discount. The factoring company then manages the receivable until it is paid. Factoring is a well-established and accepted method of temporary alternative finance that is especially well-suited for rapidly growing companies and those with customer concentrations.

2. Accounts Receivable (A/R) Financing – A/R financing is an ideal solution for companies that are not yet bankable but have a stable financial condition and a more diverse customer base. Here, the business provides details on all accounts receivable and pledges those assets as collateral. The proceeds of those receivables are sent to a lockbox while the finance company calculates a borrowing base to determine the amount the company can borrow. When the borrower needs money, it makes an advance request and the finance company advances money using a percentage of the accounts receivable.

3. Asset-Based Lending (ABL) – This is a credit facility secured by all of a company’s assets, which may include A/R, equipment and inventory. Unlike with factoring, the business continues to manage and collect its own receivables and submits collateral reports on an ongoing basis to the finance company, which will review and periodically audit the reports.

In addition to providing working capital and enabling owners to maintain business control, alternative financing may provide other benefits as well:

It’s easy to determine the exact cost of financing and obtain an increase.
Professional collateral management can be included depending on the facility type and the lender.
Real-time, online interactive reporting is often available.
It may provide the business with access to more capital.
It’s flexible – financing ebbs and flows with the business’ needs.
It’s important to note that there are some circumstances in which equity is a viable and attractive financing solution. This is especially true in cases of business expansion and acquisition and new product launches – these are capital needs that are not generally well suited to debt financing. However, equity is not usually the appropriate financing solution to solve a working capital problem or help plug a cash-flow gap.

A Precious Commodity

Remember that business equity is a precious commodity that should only be considered under the right circumstances and at the right time. When equity financing is sought, ideally this should be done at a time when the company has good growth prospects and a significant cash need for this growth. Ideally, majority ownership (and thus, absolute control) should remain with the company founder(s).

Alternative financing solutions like factoring, A/R financing and ABL can provide the working capital boost many cash-strapped businesses that don’t qualify for bank financing need – without diluting ownership and possibly giving up business control at an inopportune time for the owner. If and when these companies become bankable later, it’s often an easy transition to a traditional bank line of credit. Your banker may be able to refer you to a commercial finance company that can offer the right type of alternative financing solution for your particular situation.

Taking the time to understand all the different financing options available to your business, and the pros and cons of each, is the best way to make sure you choose the best option for your business. The use of alternative financing can help your company grow without diluting your ownership. After all, it’s your business – shouldn’t you keep as much of it as possible?

Business loans and finance for a business just may have gotten good again? The pursuit of credit and funding of cash flow solutions for your business often seems like an eternal challenge, even in the best of times, let alone any industry or economic crisis. Let’s dig in.

Since the 2008 financial crisis there’s been a lot of change in finance options from lenders for corporate loans. Canadian business owners and financial managers have excess from everything from peer-to-peer company loans, varied alternative finance solutions, as well of course as the traditional financing offered by Canadian chartered banks.

Those online business loans referenced above are popular and arose out of the merchant cash advance programs in the United States. Loans are based on a percentage of your annual sales, typically in the 15-20% range. The loans are certainly expensive but are viewed as easy to obtain by many small businesses, including retailers who sell on a cash or credit card basis.

Depending on your firm’s circumstances and your ability to truly understand the different choices available to firms searching for SME COMMERCIAL FINANCE options. Those small to medium sized companies ( the definition of ‘ small business ‘ certainly varies as to what is small – often defined as businesses with less than 500 employees! )

How then do we create our road map for external financing techniques and solutions? A simpler way to look at it is to categorize these different financing options under:

Debt / Loans

Asset Based Financing

Alternative Hybrid type solutions

Many top experts maintain that the alternative financing solutions currently available to your firm, in fact are on par with Canadian chartered bank financing when it comes to a full spectrum of funding. The alternative lender is typically a private commercial finance company with a niche in one of the various asset finance areas

If there is one significant trend that’s ‘ sticking ‘it’s Asset Based Finance. The ability of firms to obtain funding via assets such as accounts receivable, inventory and fixed assets with no major emphasis on balance sheet structure and profits and cash flow ( those three elements drive bank financing approval in no small measure ) is the key to success in ABL ( Asset Based Lending ).

Factoring, aka ‘ Receivable Finance ‘ is the other huge driver in trade finance in Canada. In some cases, it’s the only way for firms to be able to sell and finance clients in other geographies/countries.

The rise of ‘ online finance ‘ also can’t be diminished. Whether it’s accessing ‘ crowdfunding’ or sourcing working capital term loans, the technological pace continues at what seems a feverish pace. One only has to read a business daily such as the Globe & Mail or Financial Post to understand the challenge of small business accessing business capital.

Business owners/financial mgrs often find their company at a ‘ turning point ‘ in their history – that time when financing is needed or opportunities and risks can’t be taken. While putting or getting new equity in the business is often impossible, the reality is that the majority of businesses with SME commercial finance needs aren’t, shall we say, ‘ suited’ to this type of funding and capital raising. Business loan interest rates vary with non-traditional financing but offer more flexibility and ease of access to capital.

We’re also the first to remind clients that they should not forget govt solutions in business capital. Two of the best programs are the GovernmentSmall Business Loan Canada (maximum availability = $ 1,000,000.00) as well as the SR&ED program which allows business owners to recapture R&D capital costs. Sred credits can also be financed once they are filed.

Those latter two finance alternatives are often very well suited to business start up loans. We should not forget that asset finance, often called ‘ ABL ‘ by those Bay Street guys, can even be used as a loan to buy a business.

If you’re looking to get the right balance of liquidity and risk coupled with the flexibility to grow your business seek out and speak to a trusted, credible and experienced Canadian business financing advisor with a track record of business finance success who can assist you with your funding needs.